Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Springerplus|June 23, 2016
The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate-a long-term follow-up comparison and quality of life analysisSiebren Dijkstra, Wim P J Witjes, Erik P M Roos, et al.Journal of Clinical Medicine|October 16, 2024
Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1Herjan J T Coelingh Bennink, Erik P M Roos, R Jeroen A van Moorselaar, et al.Endocrine Connections|October 25, 2022
Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative reviewHerjan J T Coelingh Bennink, Jan Krijgh, Jan F M Egberts, et al.European Urology Open Science|November 10, 2022
Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi StudyYvette Zimmerman, Mark Frydenberg, Hendrik van Poppel, et al.The Journal of Urology|December 5, 2025
Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End PointsNeal D Shore, Ugo De Giorgi, Ronald F Tutrone, et al.European Urology Open Science|August 2, 2021
Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)Herjan J T Coelingh Bennink, Jeroen A van Moorselaar, E David Crawford, et al.Pageof 2